Nom du produit:trans-tert-Butyl 3-hydroxy-4-(hydroxymethyl)piperidine-1-carboxylate

IUPAC Name:tert-butyl (3S,4S)-3-hydroxy-4-(hydroxymethyl)piperidine-1-carboxylate

CAS:219975-81-2
Formule moléculaire:C11H21NO4
Pureté:98%
Numéro de catalogue:CM514919
Poids moléculaire:231.29

Unité d'emballage Stock disponible Prix($) Quantité
CM514919-1g 1-2 Weeks ƻŭň

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:219975-81-2
Formule moléculaire:C11H21NO4
Point de fusion:-
Code SMILES:O=C(N1C[C@@H](O)[C@H](CO)CC1)OC(C)(C)C
Densité:
Numéro de catalogue:CM514919
Poids moléculaire:231.29
Point d'ébullition:
N° Mdl:
Stockage:

Category Infos

Piperidines
Piperidine is an azacycloalkane that is cyclohexane in which one of the carbons is replaced by a nitrogen. Although piperidine is a common organic compound, it is an immensely important class of compounds medicinally: the piperidine ring is the most common heterocyclic subunit among FDA approved drugs.
Piperidine,Piperidine Price
if you want to know the latest news about piperidine and piperidine price, please come to our website and get a quote for free.

Column Infos

Samuraciclib
Carrick Therapeutics’ Phase 2 Clinical Trial of Samuraciclib combined with Fulvestrant has dosed its first patient. The study targets patients with CDK4/6i resistant HR+, HER2- metastatic breast cancer. Samuraciclib is a selective oral, first-in-class inhibitor of CDK7. It is involved in the regulation of cancer-causing genes, promotion of uncontrolled cell cycle progression, and increase in resistance to anti-hormone therapy. The comb previously receives the Fast Track Designation from the U.S. FDA.

Related Products